Blog
RSS FeedPosted by Michael Wonder on 27 May 2020
COVID-19: UK authorises anti-viral drug remdesivir
26 May 2020 - A drug treatment called remdesivir that appears to shorten recovery time for people with coronavirus is ...
Posted by Michael Wonder on 27 May 2020
NICE issues final guidance on NHS use of Bayer's Vitrakvi
27 May 2020 - The NICE has published final guidance recommending NHS use of Bayer's Vitrakvi (larotrectinib) for a variety ...
Posted by Michael Wonder on 27 May 2020
NICE recommends treatment for type of small-cell lung cancer
27 May 2020 - A new treatment option for patients with extensive-stage small-cell lung cancer has been approved by NICE. ...
Posted by Michael Wonder on 26 May 2020
NICE Chairman Sharmila Nebhrajani begins her new role
26 May 2020 - NICE is delighted to announce that today Sharmila Nebhrajani, OBE, has taken up her position as its ...
Posted by Michael Wonder on 22 May 2020
Improved deal means new treatment for a type of advanced breast cancer can be recommended by NICE
22 May 2020 - Draft guidance published today by NICE recommends atezolizumab for treating people with a type of breast cancer, ...
Posted by Michael Wonder on 19 May 2020
UK bulk buys hydroxychloroquine as potential COVID-19 treatment
20 May 2020 - Hydroxychloroquine is being bought in bulk by the UK in case it does turn out to ...
Posted by Michael Wonder on 13 May 2020
NICE backs drug for lymphoma from Roche
13 May 2020 - NICE has recommended NHS funding for a cancer drug, giving final guidance on a new option ...
Posted by Michael Wonder on 13 May 2020
NICE final guidance backs Pfizer's Lorviqua
13 May 2020 - NICE has published guidance recommending the use of Pfizer's Lorviqua (lorlatinib) for a certain form of ...
Posted by Michael Wonder on 11 May 2020
Exploration of the visibility of patient input in final recommendation documentation for three health technology assessment bodies
7 May 2020 - Health technology assessment recommendations informed by patient concerns are seen to ensure democracy and legitimacy. ...
Posted by Michael Wonder on 07 May 2020
NICE draft guidance recommends new treatment option for people with early breast cancer
7 May 2020 - NICE has today published draft guidance which recommends trastuzumab emtansine (also called Kadcyla and made by Roche) ...
Posted by Michael Wonder on 04 May 2020
Cost‐effectiveness and financial risks associated with immune checkpoint inhibitor therapy
1 May 2020 - The reimbursement of the immune checkpoint inhibitors is challenging. ...
Posted by Michael Wonder on 04 May 2020
AstraZeneca to make Oxford vaccine as COVID-19 race heats up
30 April 2020 - AstraZeneca agreed to make an experimental coronavirus vaccine developed by Oxford University researchers as the race ...
Posted by Michael Wonder on 30 Apr 2020
NICE joins international collaboratives to respond to the COVID-19 pandemic
30 April 2020 - NICE is supporting a growing number of international collaborations to share knowledge and identify treatments in response ...
Posted by Michael Wonder on 28 Apr 2020
In race for a coronavirus vaccine, an Oxford group leaps ahead
27 April 2020 - As scientists at the Jenner Institute prepare for mass clinical trials, new tests show their vaccine to ...
Posted by Michael Wonder on 28 Apr 2020
NICE U-turn backs Stelara for ulcerative colitis
28 April 2020 - NICE has now issued a positive Final Appraisal Document recommending Janssen's Stelara (ustekinumab) as an option ...